본문 바로가기
KERD
논문KCI 등재

A new horizon of precision medicine: combination of the microbiome and extracellular vesicles

1

조회

0

다운로드

3

인용

0

참고문헌

주제분류생화학

초록

Over several decades, the disease pattern of intractable disease has changed from acute infection to chronic disease accompanied by immune and metabolic dysfunction. In addition, scientific evidence has shown that humans are holobionts; of the DNA in humans, 1% is derived from the human genome, and 99% is derived from microbial genomes (the microbiome). Extracellular vesicles (EVs) are lipid bilayer-delimited nanoparticles and key messengers in cell-to-cell communication. Many publications indicate that microbial EVs are both positively and negatively involved in the pathogenesis of various intractable diseases, including inflammatory diseases, metabolic disorders, and cancers. Microbial EVs in feces, blood, and urine show significant differences in their profiles between patients with a particular disease and healthy subjects, demonstrating the potential of microbial EVs as biomarkers for disease diagnosis, especially for assessing disease risk. Furthermore, microbial EV therapy offers a variety of advantages over live biotherapeutics and human cell EV (or exosome) therapy for the treatment of intractable diseases. In summary, microbial EVs are a new tool in medicine, and microbial EV technology might provide us with innovative diagnostic and therapeutic solutions in precision medicine.

Abstract

Over several decades, the disease pattern of intractable disease has changed from acute infection to chronic disease accompanied by immune and metabolic dysfunction. In addition, scientific evidence has shown that humans are holobionts; of the DNA in humans, 1% is derived from the human genome, and 99% is derived from microbial genomes (the microbiome). Extracellular vesicles (EVs) are lipid bilayer-delimited nanoparticles and key messengers in cell-to-cell communication. Many publications indicate that microbial EVs are both positively and negatively involved in the pathogenesis of various intractable diseases, including inflammatory diseases, metabolic disorders, and cancers. Microbial EVs in feces, blood, and urine show significant differences in their profiles between patients with a particular disease and healthy subjects, demonstrating the potential of microbial EVs as biomarkers for disease diagnosis, especially for assessing disease risk. Furthermore, microbial EV therapy offers a variety of advantages over live biotherapeutics and human cell EV (or exosome) therapy for the treatment of intractable diseases. In summary, microbial EVs are a new tool in medicine, and microbial EV technology might provide us with innovative diagnostic and therapeutic solutions in precision medicine.

참고문헌 (132)

  1. "What is precision medicine? MedlinePlus" (2018)[URL]
  2. National Research Council, "Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease" (2011), National Academies Press
  3. Ginsburg, G. S., "Precision Medicine : From Science to Value", Health Aff, 37, pp.694~701 (2018)
  4. Ho, D., "Enabling technologies for personalized and precision medicine", Trends Biotechnol, 38, pp.497~518 (2020)
  5. "NIH Human Microbiome Project defines normal bacterial makeup of the body" (2012)[URL]
  6. Margulis, L., "Symbiosis as a Source of Evolutionary Innovation:Speciation and Morphogenesis" (1991), Mit Press
  7. "Agriculture, Environment and the Developing World: A Future of PCR. Part 4: The Hologenome Plenary lecture at Cold Spring Harbor Laboratory" (1994)[URL]
  8. Rosenberg, E., "Microbes drive evolution of animals and plants: the hologenome concept", MBio, 7, pp.e01395–15~ (2016)
  9. Bordenstein, S. R., "Host biology in light of the microbiome : ten principles of holobionts and hologenomes", PLoS Biol, 13, pp.e1002226~ (2015)
  10. Zaborowski, M. P., "Extracellular vesicles : composition, biological relevance, and methods of study", Bioscience, 65, pp.783~797 (2015)
  11. Zhou, X., "The function and clinical application of extracellular vesicles in innate immune regulation", Cell Mol. Immunol, 17, pp.323~334 (2020)
  12. Azmi, A. S., "Exosomes in cancer development, metastasis, and drug resistance : a comprehensive review", Cancer Metastasis Rev, 32, pp.623~642 (2013)
  13. Cocucci, E., "Ectosome and exosomes : shedding the confusion between extracellular vesicles", Trends Cell Biol, 6, pp.364~372 (2015)
  14. Gustafson, D., "Extracellular vesicles as protagonists of diabetic cardiovascular pathology", Front. Cardiovasc. Med, 4, pp.71~ (2017)
  15. Akers, J. C., "Biogenesis of extracellular vesicles(EV) : exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies", J. Neurooncol, 113, pp.1~11 (2013)
  16. Jinho Yang, "Microbe-derived extracellular vesicles as a smart drug delivery system", Translational and Clinical Pharmacology, 26(3), pp.103~110 (2018), 대한임상약리학회
  17. Work, E., "The chemistry and electron microscopy of an extracellular lipopolysaccharide from Escherichia coli", Ann. N. Y. Acad. Sci, 133, pp.438~449 (1966)
  18. Dorward, D. W., "Export and intercellular transfer of DNA via membrane blebs of Neisseria gonorrhoeae", J. Bacteriol, 171, pp.2499~2505 (1989)
  19. Lee, E. Y., "Gram-positive bacteria produce membrane vesicles: proteomicsbased characterization of Staphylococcus aureus-derived membrane vesicles", Proteomics, 9, pp.5425~5436 (2009)
  20. Roier, S., "Bacterial outer membrane vesicle biogenesis: a new mechanism and its implications", Microb. Cell, 3, pp.257~259 (2016)
  21. Kulp, A., "Biological functions and biogenesis of secreted bacterial outer membrane vesicles", Annu. Rev. Microbiol, 64, pp.163~184 (2010)
  22. McBroom, A. J., "Release of outer membrane vesicles by Gramnegative bacteria is a novel envelope stress response", Mol. Microbiol, 63, pp.545~558 (2007)
  23. Roier, S., "A noverl mechanism for the biogenesis of outer membrane vesicles in Gram-negative bacteria", Nat. Commun, 7, pp.10515~ (2016)
  24. Rivera, J., "Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins", Proc. Natl Acad. Sci. USA, 107, pp.19002~19007 (2010)
  25. Briaud, P., "Extracellular vesicle biogenesis and functions in grampositive bacteria", Infect. Immune, 88, pp.e00433~20 (2020)
  26. Brown, L., "Through the wall:extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi", Nat. Rev. Microbiol, 13, pp.620~630 (2015)
  27. Allocati, N., "Die for the community : an overview of programmed cell death in bacteria", Cell Death Dis, 6, pp.e1609~ (2015)
  28. Lee, E. Y., "Proteomics in gram-negative bacterial outer membrane vesicles", Mass Spectrom. Rev, 27, pp.535~555 (2018)
  29. Poste, G., "Lipid vesicles as carriers for introducing materials into cultured cells : influence of vesicle lipid composition on mechanism(s)of vesicle incorporation into cells", Proc. Natl Acad. Sci. USA, 73, pp.1603~1607 (1976)
  30. Strahl, H., "Bacterial membranes : structure, domains, and function", Annu. Rev. Microbiol, 71, pp.519~538 (2017)
  31. Lopez, D., "Exploring functional membrane microdomains in bacteria : an overview", Curr. Opin. Microbiol, 36, pp.76~84 (2017)
  32. Kooijmans, S. A., "Exosome mimetics : a novel class of drug delivery systems", Int. J. Nanomed, 7, pp.1525~1541 (2012)
  33. Baldeschwieler, J. D., "Phospholipid vesicle targeting using synthetic glycolipid and other determinants", Ann. N. Y. Acad. Sci, 446, pp.349~367 (1985)
  34. Bussian, R. W., "Jr Influence of incorporated cerebrosides on the interaction of liposomes with HeLa cells", Biochim. Biophys. Acta, 471, pp.336~ (1977)
  35. Mauk, M. R., "Vesicle targeting : timed release and specificity for leukocytes in mice by subcutaneous injection", Science, 207, pp.309~311 (1980)
  36. Mauk, M. R., "Targeting of lipid vesicles : specificity of carbohydrate receptor analogues for leukocytes in mice", Proc. Natl Acad. Sci. USA, 77, pp.4430~4434 (1980)
  37. Ashwell, G., "The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins", Adv. Enzymol. Relat. Areas Mol. Biol, 41, pp.99~128 (1974)
  38. Achord, D. T., "Inhibition of the rat clearance system for agalacto-orosomucoid by yeast mannans and by mannose", Biochem. Biophys. Res. Commun, 77, pp.409~415 (1977)
  39. Stahl, P. D., "Evidence for receptormediated binding of glycoproteins, glycoconjugates, and lysosomal glycosidases by alveolar macrophages", Proc. Natl Acad. Sci. USA, 75, pp.1399~1403 (1978)
  40. Choi, D. S., "Proteomic analysis of outer membrane vesicles derived from Pseudomonas aeruginosa", Proteomics, 11, pp.3424~3429 (2011)
  41. Jeon, J., "Proteomic analysis of extracellular vesicles derived from Propionibacterium acnes", Proteom. Clin. Appl, 11, pp.1600040~ (2017)
  42. Tartaglia, N. R., "Staphylococcus aureus extracellular vesicles elicit an immunostimulatory response in vivo on the murine mammary gland", Front Cell Infect. Microbiol, 8, pp.277~ (2018)
  43. Hong, S. W., "An important role of alpha-hemolysin in extracellular vesicles on the development of atopic dermatitis induced by Staphylococcus aureus", PLoS ONE, 9, pp.e100499~ (2014)
  44. Tsatsaronis, J. A., "Extracellular vesicle RNA: a universal mediator of microbial communication?", Trends Microbiol, 26, pp.401~410 (2018)
  45. Sjostrom, A. E., "Membrane vesicle-mediated release of bacterial RNA", Sci. Rep, 5, pp.15329~ (2015)
  46. Bitto, N. J., "Bacteria membrane vesicles transport their DNA cargo into host cells", Sci. Rep, 7, pp.7072~ (2017)
  47. Eigenbrod, T., "Bacterial RNA: An underestimated stimulus for innate immune responses", J. Immunol, 195, pp.411~418 (2015)
  48. Hong, S. W., "Extracellular vesicles derived from Staphylococcus aureus induce atopic dermatitis-like skin inflammation", Allergy, 66, pp.351~359 (2011)
  49. 김민혜, "A Metagenomic Analysis Provides a Culture-Independent Pathogen Detection for Atopic Dermatitis", Allergy, Asthma & Immunology Research, 9(5), pp.453~461 (2017), 대한천식알레르기학회
  50. Choi, E. J., "Propionibacterium acnes-derived extracellular vesicles promote Acnelike phenotypes in human epidermis", J. Invest. Dermatol, 138, pp.1371~1379 (2018)
  51. Brandt, E. B., "Exposure to allergen and diesel exhaust particles potentiates secondary allergen-specific memory responses, promoting asthma susceptibility", J. Allergy Clin. Immunol, 136, pp.295~303 (2015)
  52. Yang, J., "Importance of indoor dust biological ultrafine particles in the pathogenesis of chronic inflammatory pulmonary disease", Environ. Health Toxicol, 32, pp.e2017021~ (2017)
  53. 양진호, "The impact of bacteria-derived ultrafine dust particles on pulmonary diseases", Experimental and Molecular Medicine, 52, pp.1~10 (2020), 생화학분자생물학회[DOI]
  54. Kim, Y. S., "Extracellular vesicles derived from Gram-negative bacteria, such as Escherichia coli, induce emphysema mainly via IL-17A-mediated neutrophilic inflammation", J. Immunol, 194, pp.3361~3368 (2015)
  55. Kim, M. R., "Staphylococcus aureus-derived extracellular vesicles induce neutrophilic pulmonary inflammation via both Th1 and Th17 cell responses", Allergy, 67, pp.1271~1281 (2012)
  56. Bae, C. H., "Escherichia coli–derived and Staphylococcus aureus–derived extracellular vesicles induce MUC5AC expression via extracellular signal related kinase 1", 2 and p38 mitogen-activated protein kinase in human airway epithelial cells, 2017, pp.7, 91~98
  57. Park, K. S., "Pulmonary inflammation induced by bacteria-free outer membrane vesicles from Pseudomonas aeruginosa", Am. J. Respir. Cell Mol. Biol, 49, pp.637~645 (2013)
  58. Yang, D., "Dysregulated lung commensal bacteria drive interleukin-17B production to promote pulmonary fibrosis through their outer membrane vesicles", Immunity, 50, pp.692~706 (2019)
  59. Kim, Y. S., "Extracellular vesicles, especially derived from Gram-negative bacteria, in indoor dust induce neutrophilic pulmonary inflammation associated with both Th1 and Th17 cell responses", Clin. Exp. Allergy, 43, pp.443~454 (2013)
  60. Ellis, T. N., "Virulence and immunomodulatory roles of bacterial outer membrane vesicles", Microbiol. Mol. Biol. Rev, 74, pp.81~94 (2010)
  61. 김유선, "IgG Sensitization to Extracellular Vesicles in Indoor Dust Is Closely Associated With the Prevalence of Non-Eosinophilic Asthma, COPD, and Lung Cancer", Allergy, Asthma & Immunology Research, 8(3), pp.198~205 (2016), 대한천식알레르기학회
  62. Shin, T. S., "Impact of gut microbiota extracellular vesicles on inflammatory and metabolic disease", J. Clin. Nutr. Food Sci, 2, pp.73~78 (2019)
  63. Tlaskalová-Hogenová, H., "The role of gut microbiota(commensal bacteria)and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer : Contribution of germ-free and gnotobiotic animal models of human diseases", Cell Mol. Immunol, 8, pp.110~120 (2011)
  64. Michielan, A., "Intestinal permeability in inflammatory bowel disease : pathogenesis, clinical evaluation, and therapy of leaky gut", Mediators Inflamm, 2015, pp.628157~ (2015)
  65. Rubino, S. J., "Nod-like receptors in the control of intestinal inflammation", Curr. Opin. Immunol, 24, pp.398~404 (2012)
  66. Bielig, H., "NOD-like receptor activation by outer membrane vesicles from Vibrio cholerae non-O1 nonO1390 strains is modulated by the quorum-sensing regulator HapR", Infect. Immune, 79, pp.1418~1427 (2011)
  67. Canas, M. A., "Outer membrane vesicles from probiotic and commensal Escherichia coli activate NOD1-mediated immune responses in intestinal epithelial cells", Front. Microbiol, 9, pp.498~ (2018)
  68. Gilmore, W. J., "Immunomodulatory roles and novel applications of bacterial membrane vesicles", Mol. Immunnol, 134, pp.72~85 (2021)
  69. Mun Sun Choi, "Helicobacter pylori-derived outer membrane vesicles stimulate interleukin 8 secretion through nuclear factor kappa B activation", The Korean Journal of Internal Medicine, 36(4), pp.857~867 (2021), 대한내과학회[DOI]
  70. Kasubuchi, M., "Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation", Nutrients, 7, pp.2839~2849 (2015)
  71. Choi, Y., "Gut microbe-derived extracellular vesicles induce insulin resistance, thereby impairing glucose metabolism in skeletal muscle", Sci. Rep, 5, pp.15878~ (2015)
  72. Seyama, M., "Outer membrane vesicles of Porphyromonas gingivalis attenuate insulin sensitivity by delivering gingipains to the liver", Biochim. Biophys. Acta, 1866, pp.165731~ (2020)
  73. Duan, M. C., "The Treg", Th17 paradigm in lung cancer, 2014, pp.2014, 730380~
  74. Reppert, S., "A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer", Nat. Commun, 2, pp.600~ (2011)
  75. Li, Y., "Effects of IL-17A on the occurrence of lung adenocarcinoma", Cancer Biol. Ther, 12, pp.610~616 (2011)
  76. Koyama, K., "Reciprocal CD4+ T-cell balance of effector CD62Llow CD4+and CD62LhighCD25+ CD4+ regulatory T cells in small cell lung cancer reflects disease stage", Clin. Cancer Res, 14, pp.6770~6779 (2008)
  77. 최현일, "Helicobacter pylori-derived extracellular vesicles increased in the gastric juices of gastric adenocarcinoma patients and induced inflammation mainly via specific targeting of gastric epithelial cells", Experimental and Molecular Medicine, 49, pp.1~13 (2017), 생화학분자생물학회
  78. Cuesta, C. M., "Role of microbiota-derived extracellular vesicles in gut-brain communication", Int. J. Mol. Sci, 22, pp.4235~ (2021)
  79. Han, E. C., "Extracellular RNAs in periodontopathogenic outer membrane vesicles promote TNF-α production in human macrophages and cross the blood-brain barrier in mice", FASEB J, 33, pp.13412~13422 (2019)
  80. Ha, J. Y., "Delivery of periodontopathogenic extracellular vesicles to brain monocytes and microglial IL-6promotion by RNA cargo", Front. Mol. Biosci, 7, pp.596366~ (2020)
  81. Lee, K. E., "The extracellular vesicle of gut microbial Paenalcaligenes hominis is a risk factor for vagus nerve-mediated cognitive impairment", Microbiome, 8, pp.107~ (2020)
  82. 양진호, "Brain tumor diagnostic model and dietary effect based on extracellular vesicle microbiome data in serum", Experimental and Molecular Medicine, 52, pp.1~12 (2020), 생화학분자생물학회[DOI]
  83. Choi, E. B., "Decreased diversity of nasal microbiota and their secreted extracellular vesicles in patients with chronic rhinosinusitis based on a metagenomic analysis", Allergy, 69, pp.517~526 (2014)
  84. Castelino, M., "Optimisation of methods for bacterial skin microbiome investigation: primer selection and comparison of the 454 versus MiSeq platform", BMC Microbiol, 17, pp.23~ (2017)
  85. Balvociute, M., "SILVA, RDP, Greengenes, NCBI and OTT - how do these taxonomies compare?", BMC Genomics, 18, pp.114~ (2017)
  86. Hendriksen, J. M. T., "Diagnostic and prognostic prediction models", J. Thromb. Haemost, 11, pp.129~141 (2013)
  87. Ju Hwan Seo, "The market trend analysis and prospects of cancer molecular diagnostics kits", 생체재료학회지, 22(1), pp.38~45 (2018), 한국생체재료학회[DOI]
  88. Lee, J. H., "Metagenome analysis using serum extracellular vesicles identified distinct microbiota in asthmatics", Sci. Rep, 10, pp.15125~ (2020)
  89. 양진호, "Diagnostic Models for Atopic Dermatitis Based on Serum Microbial Extracellular Vesicle Metagenomic Analysis: A Pilot Study", Allergy, Asthma & Immunology Research, 12(5), pp.792~805 (2020), 대한천식알레르기학회[DOI]
  90. Kim, D. J., "Colorectal cancer diagnostic model utilizing metagenomic and metabolomic data of stool microbial extracellular vesicles", Sci. Rep, 10, pp.2860~ (2020)
  91. Cho, E. J., "Circulating microbiota-based metagenomic signature for detection of hepatocellular carcinoma", Sci. Rep, 9, pp.7536~ (2019)
  92. Park, J. Y., "Bacteria-derived extracellular vesicles in urine as a novel biomarker for gastric cancer: integration of liquid biopsy and metagenome analysis", Cancers, 13, pp.4687~ (2021)
  93. Kim, J. R., "Microbiome markers of pancreatic cancer based on bacteriaderived extracellular vesicles acquired from blood samples: a retrospective propensity score matching analysis", Biology, 10, pp.219~ (2021)
  94. Lee, H., "16S rDNA microbiome composition pattern analysis as a diagnostic biomarker for biliary tract cancer", World J. Surg. Oncol, 18, pp.19~ (2020)
  95. Kim, S. I., "Metagenomic analysis of serum microbe-derived extracellular vesicles and diagnostic models to differentiate ovarian cancer and benign ovarian tumor", Cancers, 12, pp.1309~ (2020)
  96. Jinho Yang, "Lung Disease Diagnostic Model Through IgG Sensitization to Microbial Extracellular Vesicles", Allergy, Asthma & Immunology Research, 12(4), pp.669~683 (2020), 대한천식알레르기학회
  97. Shahina Akter, "Potential Health-Promoting Benefits of Paraprobiotics, Inactivated Probiotic Cells", Journal of Microbiology and Biotechnology, 30(4), pp.477~481 (2020), 한국미생물·생명공학회
  98. Taverniti, V., "The immunomodulatory properties of probiotic microorganisms beyond their viability(ghost probiotics : proposal of paraprobiotic concept)", Genes Nutr, 6, pp.261~274 (2011)
  99. de Almada, C. N., "Paraprobiotics : evidences on their ability to modify biological responses, inactivation methods and perspectives on their application in foods", Trends Food Sci. Technol, 58, pp.96~114 (2016)
  100. Pique, N., "Health benefits of heat-killed(tyndallized)probiotics : an overview", Int. J. Mol. Sci, 20, pp.2534~ (2019)
  101. Aguilar-Toala, J. E., "Postbiotics: an evolving term within the functional foods field", Trends Food Sci. Technol, 75, pp.105~114 (2018)
  102. Fafian-Labora, J. A., "Classical and nonclassical intercellular communication in senescence and ageing", Trends Cell Biol, 30, pp.628~639 (2020)
  103. Liu, Y., "Gram-positive bacterial extracellular vesicles and their impact on health and disease", Front. Microbiol, 9, pp.1502~ (2018)
  104. Kang, C. S., "Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodiuminduced colitis", PLoS ONE, 8, pp.e76520~ (2013)
  105. Ji Hyun Choi, "Lactobacillus paracasei-derived extracellular vesicles attenuate the intestinal inflammatory response by augmenting the endoplasmic reticulum stress pathway", Experimental and Molecular Medicine, 52, pp.1~15 (2020), 생화학분자생물학회[DOI]
  106. Chaithanya Chelakkot, "Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions", Experimental and Molecular Medicine, 50, pp.1~11 (2018), 생화학분자생물학회
  107. 김민혜, "Lactobacillus plantarum-derived Extracellular Vesicles Protect Atopic Dermatitis Induced by Staphylococcus aureus-derived Extracellular Vesicles", Allergy, Asthma & Immunology Research, 10(5), pp.516~532 (2018), 대한천식알레르기학회
  108. Kim, W., "Lactobacillus plantarum-derived extracellular vesicles induce antiinflammatory M2 macrophage polarization in vitro", J. Extracell. Vesicles, 9, pp.1793514~ (2020)
  109. Seo, M. K., "Therapeutic effects of kefir grain Lactobacillus-derived extracellular vesicles in mice with 2, 4, 6-trinitrobenzene sulfonic acid-induced inflammatory bowel disease", J. Dairy Sci, 101, pp.8662~8671 (2018)
  110. Miyoshi, Y., "Mechanisms underlying enhanced IgA production in Peyer’s patch cells by membrane vesicles derived from Lactobacillus sakei", Biosci. Biotechnol. Biochem, 85, pp.1536~1545 (2021)
  111. Kim, J. H., "Extracellular vesicle–derived protein from Bifidobacterium longum alleviates food allergy through mast cell suppression", J. Allergy Clin. Immunol, 137, pp.507~516 (2016)
  112. Wang, J., "The outer membrane protein Amuc_1100 of Akkermansia muciniphila promotes intestinal 5-HT biosynthesis and extracellular availability through TLR2 signalling", Food Funct, 12, pp.3597~3610 (2021)
  113. Poste, G., "Lipid vesicles as carriers for introducing biologically active materials into cells", Methods Cell Biol, 14, pp.33~71 (1976)
  114. Sambi, M., "Current challenges in cancer immunotherapy : multimodal approaches to improve efficacy and patient response rates", J. Oncol, 2019, pp.4508794~ (2019)
  115. Kim, O. Y., "Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response", Nat. Commun, 8, pp.626~ (2017)
  116. Evanovich, E., "Comparative genomic analysis of Lactobacillus plantarum: an overview", Int. J. Genomics, 2019, pp.4973214~ (2019)
  117. Juli Choi, "Extracellular Vesicles Derived from Lactobacillus plantarum Increase BDNF Expression in Cultured Hippocampal Neurons and Produce Antidepressant-like Effects in Mice", Experimental Neurobiology, 28(2), pp.158~171 (2019), 한국뇌신경과학회
  118. Tian, F., "The therapeutic protection of a living and dead Lactobacillus strain against aluminum-nduced brain and liver injuries in C57BL", 6 mice, 2017, pp.12, e0175398~
  119. Davis, D. J., "Lactobacillus plantarum attenuates anxiety-related behavior and protects against stress-induced dysbiosis in adult zebrafish", Sci. Rep, 6, pp.33726~ (2016)
  120. Dhaliwal, J., "Lactobacillus plantarum MTCC 9510 supplementation protects from chronic unpredictable and sleep deprivation-induced behaviour, biochemical and selected gut microbial aberrations in mice", J. Appl. Microbiol, 125, pp.257~269 (2018)
  121. Bin, L., "Staphylococcus aureus alpha-toxin modulates skin host response to viral infection", J. Allergy Clin. Immunol, 130, pp.683~691 (2012)
  122. 이윤진, "Rapid Assessment of Microbiota Changes in Individuals with Autism Spectrum Disorder Using Bacteria-derived Membrane Vesicles in Urine", Experimental Neurobiology, 26(5), pp.307~317 (2017), 한국뇌신경과학회
  123. Rhee, S. J., "Comparison of serum microbiome composition in bipolar and major depressive disorders", J. Psychiatr. Res, 123, pp.31~38 (2020)
  124. Samra, M., "Urine bacteria-derived extracellular vesicles and allergic airway diseases in children", Int. Arch. Allergy Immunol, 178, pp.150~158 (2019)
  125. You, Y. A., "Blood microbial communities during pregnancy are associated with preterm birth", Front. Microbiol, 10, pp.1122~ (2019)
  126. Kim, S. S., "Microbiome as a potential diagnostic and predictive biomarker in severe alcoholic hepatitis", Aliment Pharmacol. Ther, 53, pp.540~551 (2021)
  127. Shen, Y., "Outer membrane vesicles of a human commensal mediate immune regulation and disease protection", Cell Host Microbe, 12, pp.509~520 (2021)
  128. Lopez, P., "Treg-inducing membrane vesicles from Bifidobacterium bifidum LMG13195 as potential adjuvants in immunotherapy", Vaccine, 30, pp.825~829 (2012)
  129. Maerz, J. K., "Outer membrane vesicles blebbing contributes to B. vulgatus mpk-mediated immune response silencing", Gut Microbes, 9, pp.1~12 (2018)
  130. Kim, O. Y., "Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response", Nat. Commun, 8, pp.626~ (2017)
  131. An, J., "Bacterial extracellular vesicles affect endocrine therapy in MCF7 cells", Medicine, 100, pp.e25835~ (2021)
  132. AI-Nedawi, K., "Gut commensal microvesicles reproduce parent bacterial signals to host immune and enteric nervous systems", FASEB J, 29, pp.684~695 (2014)

관련 논문AI추천

이 간행물의 다른 논문 (191건)